Plaster for treating hyperosteogeny

Abstract

The invention relates to a plaster for treating hyperosteogeny, which is prepared from the following raw materials: sesame oil, yellow lead, draconis sanguis, centipede, borneol, radix clematidis, notopterygium root, raw kusnezoff monkshood, radix sileris, white mustard seed, earthworm, clove, spatholobus stem, black-tail snake, rhizoma drynariae, rhizoma sparganii, azone and nano ceramic powder.The preparation method comprises the following contents: preparing an ointment substrate by the sesame oil and the yellow lead; pulverizing the draconis sanguis, the centipede and the borneol into powder which is sieved by a sieve of 110 meshes and obtaining medicine material powder; after decocting other medicine materials with water, taking decoction, removing residues, concentrating the obtained medicine decoction and obtaining a medicine material extract; after dissolving the ointment substrate, adding the medicine material extract, the medicine material powder, the nano ceramic powder and the azone to obtain the ointment; and spreading the ointment on a backing material so as to obtain the plaster. The plaster for treating the hyperosteogeny, which is provided by the invention, has the characteristics of accurate application, strong permeability and high content of effective components and has better curative effect for treating the hyperosteogeny.

Description

technical field [0001] The invention relates to a plaster for treating hyperosteogeny. Background technique [0002] At present, in clinical practice, traction, massage, or oral medicine or infusion are usually used for treatment of bone hyperplasia. Oral medicine is more irritating to the gastrointestinal tract, which is unbearable for patients, and infusion will cause varying degrees of damage to the liver and kidney. . The use effect of some existing plasters for treating hyperosteogeny is also not satisfactory, and its main reason is: the selection of raw materials is not precise enough, the active ingredient content in the plaster is low, and the permeability of the plaster is not good. Contents of the invention [0003] The object of the present invention is to provide a plaster for treating hyperosteogeny, which has accurate materials, high active ingredient content and good permeability. [0004] In order to achieve the above objectives, the following schemes are...

AI Technical Summary

Problems solved by technology

[0002] At present, in clinical practice, traction, massage, or oral medicine or infusion are usually used for treatment of bone hyperplasia. Oral medicine is more irritating to the gastrointestinal tract, which is unbearable for patients, and infusion will cause varying degrees of damage to the liver and kidney.

The use effect of some existing plasters for treating hyperosteogeny is not satisfactory, and its main reason is: raw material selection is not precise enough, active ingredient content in the plaster is low, the permeability of plaster is not good